Dave Holden

Dave Holden has a diverse range of work experience. Dave started their career as an Intern Financial Analyst at Marine Capital Ltd in 2010. Dave then worked as an Analyst at Operis from 2011 to 2012, where they focused on analyzing financial models for infrastructure projects. Dave then transitioned to the field of law, working as a Part-Qualified Patent Attorney in the field of Biotechnology at Carpmaels & Ransford from 2012 to 2014. During this time, they prosecuted and drafted European patent applications related to biotechnology.

In 2014, Dave pursued a Masters in Bioscience Enterprise at the University of Cambridge, where they gained knowledge in biotechnology, business, and bio-entrepreneurship. Dave then briefly worked as a Research Scholar at ICTI: International Centre for Technological Innovations in 2014.

From 2015 to 2017, Dave worked in Corporate Development at Psyomics, an early-stage biotechnology company focused on improving the prevention, diagnosis, and treatment of neuropsychiatric disorders through biomarker diagnostics. Currently, Dave is the CEO of Techspert, a global leader in the healthcare and life sciences sector that uses unique search technology to connect businesses to experts for smarter decision-making.

Dave Holden has a Master's Degree in Bioscience Enterprise from the University of Cambridge, which they obtained from 2014 to 2015. Prior to that, they completed a Master's Degree in Biochemistry at the University of Oxford from 2007 to 2011. In 2013-2014, they also earned a Certificate in Intellectual Property from Queen Mary University of London, specializing in the field of Intellectual Property.